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Abstract  
 
Purpose: Accelerometers are increasingly being used to assess physical activity in large-scale surveys. 
Establishing whether key physical activity outcomes can be considered equivalent between three widely-used 
accelerometer brands would be a significant step towards capitalising on the increasing availability of 
accelerometry data for epidemiological research. Methods: Twenty participants wore a GENEActiv, Axivity 
AX3 and ActiGraph GT9X on their non-dominant wrist and were observed for two-hours in a simulated living 
space. Participants undertook a series of seated and upright light/active behaviours at their own pace. All 
accelerometer data were processed identically using open-source software (GGIR) to generate physical 
activity outcomes (including average dynamic acceleration (ACC) and time within intensity cut-points). Data 
were analysed using pairwise 95% equivalence tests (±10% equivalence zone), intra-class correlation 
coefficients (ICC) and limits of agreement. Results: The GENEActiv and Axivity could be considered 
equivalent for ACC (ICC=0.95, 95% confidence interval (CI) 0.87 to 0.98), but ACC measured by the 
ActiGraph was approximately 10% lower (ICC: GENEActiv/ActiGraph 0.86, 95% CI 0.56 to 0.95; 
Axivity/ActiGraph 0.82, 95% CI 0.50 to 0.94). For time spent within intensity cut-points, all three 
accelerometers could be considered equivalent to each other for over 85% of outcomes (ICC>0.69, lower 95% 
CI>0.36), with the GENEActiv and Axivity equivalent for 100% of outcomes (ICC>0.95, lower 95% 
CI>0.86). Conclusions: GENEActiv and Axivity data processed in GGIR are largely equivalent. If comparing 
GENEActiv or Axivity to the ActiGraph, time spent within intensity cut-points has good agreement. These 
findings can be used to inform selection of appropriate outcomes if comparing outputs from these 
accelerometer brands. 
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Introduction 
 
Pooling data from multiple surveys has facilitated robust and generalizable estimates of risk factors (e.g. 
smoking, overweight) for cardiovascular events, cardiovascular disease and mortality that have informed 
clinical and public health practice (1, 2). Physical inactivity is also an established risk factor for chronic disease 
(3) but, until recently, physical activity measurement in epidemiological and surveillance studies has relied 
on self-report. This is imprecise which has complicated comparison or aggregation of data across populations.  
 
Over the past few years, it has become feasible to move to large-scale objective measurement of physical 
activity with wrist-worn accelerometers worn 24 hours a day, seven days a week. As the latest generation of 
accelerometers measure acceleration in SI units, there is great potential for aggregation of measures of 
physical activity into very large multinational databases. Data harmonisation would facilitate a step-change in 
our ability to: a) compare prevalence or levels of activity/inactivity across populations, b) quantify dose-
response associations between activity and health and c) to identify the factors that impact on these 
associations. A key advantage would be the ability to address these questions in very large samples across 
countries and/or populations for a wide range of health outcomes. 
 
There are three brands of accelerometers providing acceleration data in SI units being used in large surveys: 
the Axivity, ActiGraph, and GENEActiv. For example, UK Biobank, a large-scale prospective 
epidemiological resource containing baseline phenotypic and genotypic data on 500,000 participants, has 
recently used the Axivity wrist-worn accelerometer in over 100,000 participants (4) and the Breakthrough 
Generation Study (5) has used the Axivity on 4,800 women to date. The US National Health and Nutrition 
Examination Survey (NHANES) used the ActiGraph wrist-worn accelerometer in cycles 2011-2012 and 2013-
2014 (approximately 9,000-10,000 participants examined per cycle). The Pelotas Birth Cohort (6), the 
Melbourne Child Health Checkpoint (7), the Cork Children’s Lifestyle Study (8), and the British Whitehall II 
study (9) used the GENEActiv in approximately 10,000, 4,000, 1,000 and 3,750 participants, respectively. 
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Before outcomes from studies using different brands of accelerometer can be pooled into multinational 
databases, it is necessary to demonstrate comparability of data outputs between brands. 
 
Pooling accelerometer data from these studies is more viable now than ever before. Earlier accelerometers 
processed data into counts using proprietary algorithms (10); this complicated the interpretation and 
comparison of data from studies using different devices (11). However, evidence suggests that, despite the 
outcome being non-proprietary accelerations, data may not be equivalent between brands (12, 13, 14, 15, 16).  
 
To facilitate transparent processing of these raw data the generation and use of open-source resources is 
encouraged (16, 18). GGIR is an open-access package in R [http:/cran.r-project.org] that can be used to 
process and analyse raw accelerations from the GENEActiv and the Actigraph using identical methods (17, 
18, 19, 20). As it is open-source and an efficient method for processing and analysing raw data to obtain the 
key outcomes required for characterising habitual physical activity it has been used widely to analyse 
GENEActiv and ActiGraph data (e.g. 6, 9, 20, 21, 22, 23, 24, 25, 26). We have shown that the outcomes from 
GENEActiv and ActiGraph processed through GGIR are broadly comparable, although comparisons at lower 
magnitudes of acceleration may be problematic (20). More focussed assessment of specific sedentary and light 
activities is needed to examine this further.  
 
The Axivity and GENEActiv measured similar magnitudes of accelerations when tested in a mechanical 
shaker (27), but there are no data comparing the Axivity and ActiGraph or comparing physical activity 
outcomes from the Axivity to the GENEActiv or ActiGraph during actual wear. This paper will introduce a 
function that converts raw Axivity files to a format that facilitates identical processing and analysis of Axivity 
files in GGIR. It is important to consider the accelerometer, processing and analysis together when establishing 
whether outcomes can be considered equivalent or not, as each of these steps can impact on the final outcome 
variable (16). Given the widespread use of a) these accelerometers to assess physical activity and b) GGIR for 
processing and analysis of the data, establishing which outcomes can be considered equivalent between 
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accelerometers would be a significant step towards capitalising on the increasing availability of 
accelerometry data in epidemiological research.  
 
We aimed to establish whether the Axivity, GENEActiv and ActiGraph GT9X result in equivalent physical 
activity outcomes when data are processed and analysed identically with GGIR. We considered the magnitude 
of acceleration, time spent above and below published intensity cut-points and the distribution of time across 
an incremental acceleration range, both for specific activities and for the duration of a simulated free-living 
situation in a laboratory. 
 
Methods 
 
A convenience sample of 20 adult participants was recruited from Loughborough University and University 
of Leicester (staff and students) via email and word of mouth. All participants provided written informed 
consent, and the study was approved by the Ethics Committee of Loughborough University. Data were 
collected between January and April 2016.  
 
Height and body mass were measured to the nearest 0.5 cm and 0.1 kg, respectively. Each participant was 
fitted with an Axivity AX3 (Axivity Ltd, Newcastle, UK), GENEActiv (ActivInsights Ltd, Cambridgeshire, 
UK) and ActiGraph GT9X Link (ActiGraph LLC, Pensacola, FL, USA) on their non-dominant wrist. This 
was part of a larger study employing further activity monitors; to reduce the need for multiple wrist-straps the 
Axivity was taped to the GENEActiv and the ActiGraph was worn immediately proximal to the GENEActiv 
and Axivity. In our previous studies comparing output from the GENEActiv and the ActiGraph, differences 
in output were consistent whether the monitors were taped together (12, 28) or worn adjacent on the wrist 
(20).  
 
Protocol 
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The study took place in a laboratory mocked up as a living space with items of furniture and lasted 
approximately two hours with participants tested in groups of two or three. Participants were asked to 
undertake a series of seated activities (watching television, using the computer, eating and reading) in any 
manner, at their own pace and in any order they chose. Minimal instructions were given with participants 
simply asked to ensure they undertook each activity at least once and for a minimum of 10 min. The aim was 
to mimic free-living postures/behaviours as closely as possible. A researcher observed the participants 
continuously and recorded their activity and posture (seated or standing) minute-by-minute. Participants then 
performed six upright light and active behaviours in a randomised order for five minutes each: standing still, 
standing up to work on a computer, dusting, sweeping, washing pots and walking.  
 
Accelerometers 
The Axivity AX3, GENEActiv and ActiGraph GT9X Link (from herein: Axivity, GENEActiv and ActiGraph) 
are triaxial accelerometry-based activity monitors with a dynamic range of +/- 8 g, where g is equal to the 
Earth’s gravitational pull. All accelerometers were set to capture and store accelerations at their maximum 
sampling frequency of 100 Hz. The “idle sleep mode” in the ActiGraph software (Actilife v. 6.13.0) was 
disabled. Axivity data were downloaded using OmGui open-source software (OmGui Version 1.0.0.28, Open 
Movement, Newcastle University, UK) and saved in raw format as .cwa files. GENEActiv data were 
downloaded using GENEActiv PC software version 2.2 and saved in raw format as .bin files. ActiGraph data 
were downloaded using ActiLife v. 6.13.0, saved in raw format as .gt3x files and converted to .csv format for 
data processing.  
 
Data processing and outcome measures 
Raw .cwa Axivity files were converted to .bin files using our new function, 
‘AccelerometerCWA2BINConverter’, to enable analysis in GGIR, thus identical processing and analysis as 
GENEActiv and ActiGraph files. This function includes resampling of the data to a standard frequency as 
specified in the header of the cwa file; this is necessary because the Axivity sample frequency is unreliable 
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and varies over time. This function is available at: 
https://github.com/Mirkes/AccelerometerCWA2BINConverter. 
 
All accelerometer files were analysed with R-package GGIR version 1.4 in R (http://cran.r-project.org)  (18, 
19). This included auto-calibration using local gravity as a reference (19), detection of sustained abnormally 
high values, calculation of the average magnitude of dynamic acceleration (i.e. resultant vector magnitude, 
corrected for gravity and expressed as Euclidean Norm Minus One (ENMO) in milli-gravitational units (mg) 
averaged over 1-second epochs) and generation of participant-specific csv files with accelerometer output in 
1 s epochs. Where insufficient non-movement periods were available for auto-calibration we used back-up 
calibration coefficients derived from free-living data collected with the same accelerometer unit.   
 
A number of pre-specified outcomes were assessed: average acceleration (mg); % time accumulated within 
cut-points for sedentary, light and moderate-to-vigorous physical activity (MVPA); distribution of time across 
acceleration levels in 40 mg resolution (0-40 mg, 40-80 mg... >200 mg). Mean acceleration was calculated 
for each activity separately, seated activities only, upright activities only and over the total time period (i.e. 
including all activities and transitions, approximately two hours). Cut-point and distribution of time outcomes 
were calculated for seated activities only, upright activities only and over the total time period. 
 
Time spent sedentary and time in light activity were calculated using cut-points of 30, 40 and 50 mg to enable 
evaluation of the equivalency of a range of sedentary cut-points (14, 15). The accuracy of these cut-points was 
further calculated for seated activity (i.e. % seated time classified as sedentary) and for upright activity (i.e. 
% upright time classified as not sedentary). MVPA was calculated using an acceleration cut-point of 100 mg 
(13). All outcomes were calculated for all three devices. 
 
Data analysis 
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Descriptive statistics (mean (SD)) were calculated for all outcomes. The level of agreement between outputs 
from the three brands of accelerometer was determined pairwise using intraclass correlation coefficients (ICC, 
single measures, absolute agreement) with 95% confidence intervals (CI) and limits of agreement (LoA) (29). 
We used pairwise 95% equivalence tests to determine whether the 95% CI for the mean of one accelerometer 
fell within a proposed equivalence zone of the second accelerometer (30). We selected ±10% of the mean as 
our proposed equivalence zone as in previous studies comparing activity monitors (31, 32). Equivalence 
results are presented with the reference accelerometer selected according to the following hierarchy: 
GENEActiv, Axivity, ActiGraph. However, as no accelerometer can be considered the gold standard this was 
arbitrary, consequently all equivalence analyses were repeated with the alternate accelerometer in each pairing 
selected as the reference to test whether this affected the conclusions.  
 
Based on our previous work comparing GGIR physical activity outputs from the GENEActiv and the 
ActiGraph (20), we anticipated the standard deviation of the differences between the log transformed outputs 
from the two accelerometers would be less than 0.05 mg and the ratio between the mean outputs from the two 
accelerometers would be within 1 ± 0.05. Log transforming the data enables hypotheses about ratios to be 
analysed in terms of differences. Given this effect size, using Minitab (v17), we determined that a sample size 
of 12 was required to provide 90% power (alpha = 0.05) to conclude that the difference between physical 
activity outcomes from a pair of accelerometers was within 10% of the mean when this was in fact true. 
 
Descriptive statistics, ICCs and LoA were conducted in IBM SPSS Statistics v22.0. Equivalency testing and 
power analyses were carried out in Minitab (v17). Alpha was set at 0.05. 
 
Results 
 
Twenty participants (13 females, 7 males; age (mean (SD)): 23.2 (5.9) y; body mass index: 25.2 (3.6) kg.m-2) 
took part. The Axivity accelerometers were unavailable for one testing session (three participants), one 
GENEActiv file and two ActiGraph files did not process, and one participant did not complete the seated 
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activities. Therefore the sample included 17 Axivity, 19 GENEActiv, and 18 ActiGraph files for the overall 
time period and upright activities and 16, 18 and 18, respectively, for seated activities. Pairwise N’s were 16 
for GENEActiv/Axivity, 17 for GENEActiv/ActiGraph and 15 for Axivity/ActiGraph, exceeding the sample 
size of 12 required to achieve 90% power. Participant characteristics were similar for included and excluded 
files. Running the analyses with listwise deletion did not change the results (N=14), so pairwise analyses were 
retained to maximise sample sizes.  
 
TABLE 1 HERE 
 
 
The total testing period lasted approximately 2 h and included 1 h 20 min of seated activities, 24 min of upright 
activities and 16 min of transition between activities. Descriptive statistics are presented in Table 1 and 
agreement statistics in Table 2.  
 
Acceleration (mg) 
Agreement between pairs of accelerometers was largely good, with ICCs of 0.82-0.95 for the total period, 
0.73-0.85 for all seated activities combined (except the Axivity/ActiGraph pairing, ICC = 0.59) and 0.75-0.97 
all upright activities combined, Table 2. Results for specific activities suggested that the poorest agreement 
between pairs of accelerometers was obtained when using the computer (sitting or standing) and reading. 
Although the mean biases between pairs of accelerometers tended to be low, some of the 95% LoA were 
relatively large, particularly for the Axivity/ActiGraph pairing.  
 
Overall, the highest agreement was between the GENEActiv and Axivity devices (ICC = 0.95, 95% CI: 0.87, 
0.98; mean bias = -0.1 mg, 95% limits = ±6.8 mg), which could be considered equivalent  (i.e. the 95% CI for 
the mean of the Axivity fell within ±10% of the mean of the GENEActiv) for the total period (Figure 1a), 
upright activities combined (Figure 1a) and four of the ten specific activities (not for seated activities, standing 
still or standing computer, Figures 1b and 1c). In contrast, the ActiGraph could not be considered equivalent 
to either the GENEActiv or the Axivity at all (Figures 1b and 1c). 
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TABLE 2 HERE 
FIGURE 1 HERE 
 
Sedentary, light intensity and MVPA cut-points 
Agreement between accelerometers was good for classification of sedentary time (ICC >0.84; mean bias <±1.5 
percentage points) for all accelerometer pairings, irrespective of cut-point, and all could be considered 
equivalent (Table 3, Figure 1d). The 95% LoA were narrowest for the 50 mg cut-point (Table 3).  All 
accelerometers could also be considered equivalent for classification of light intensity activity (Figure 1d), 
with pairings weakest for the 30 mg cut-point (ICC >0.69). As for classification as sedentary, the highest 
ICC’s (>0.83), lowest mean biases (<±0.3 percentage points) and narrowest 95% limits of agreement were 
found for the 50 mg cut-point. Although ICCs for classification of MVPA were high (>0.84) LoA were large 
(±2.3 – 4.1 percentage points) relative to the means (approx. 13%) and only the GENEActiv/Axivity pairing 
could be considered equivalent (Figure 1d). 
 
Although, all accelerometer pairings could be considered equivalent for six out of seven outcomes, the highest 
agreement was found for the GENEActiv and Axivity device, irrespective of cut-point (ICC >0.95, mean bias 
<±0.4 percentage points, 95% limits <±5 percentage points). 
 
TABLE 3 HERE 
 
Accuracy of sedentary cut-points 
Accuracy of classification of seated activities as sedentary was high for all cut-points (>87%), Table 1, and 
equivalent between accelerometers (Table 4, Figure 1e). However, the upright activities were misclassified 
approximately 60% of the time with the 30 mg cut-point and only equivalent for the GENEActiv/Axivity 
pairing. When applying the 40 mg or 50 mg cut-point, the upright activities were still misclassified 
approximately 50% of the time, but all accelerometers could be considered to have equivalent accuracy. 
 
 11 
Again, the highest agreement was found for the GENEActiv and Axivity device, irrespective of cut-point 
(ICC >0.83, mean bias <±1.3 percentage points, 95% limits <±5.5 percentage points). 
 
TABLE 4 HERE 
 
Incremental acceleration ranges 
Agreement was high for all accelerometer pairings for % time in 40 mg increments (ICC >0.71, mean bias 
<±1.6 percentage points). As with average mg and time spent in cut-point categories, the strongest agreement 
was for the GENEActiv and Axivity pairing (>0.93, mean bias >±0.25 percentage points), which could be 
considered equivalent for all categories, except 160-200 mg, which was borderline equivalent (Table 5, Figure 
1f). The GENEActiv/ActiGraph and Axivity/ActiGraph pairings could be considered equivalent in the 0-40, 
40-80 and 80-120 mg categories (Figure 1f). 
 
The highest agreement was found for the GENEActiv and Axivity device, irrespective of 40 mg range (ICC 
>0.93, mean bias <±0.25 percentage points, 95% limits <±4.0 percentage points). 
 
TABLE 5 HERE 
 
 
Re-running the equivalence analyses with the alternate accelerometer selected as the reference did not impact 
on whether accelerometer brands were considered equivalent or not, except two cases which were previously 
borderline, but could be considered equivalent when the alternate accelerometer was the reference. These 
were: 1) accuracy of the sedentary cut-point, 30 mg, for classification as upright by the ActiGraph and the 
Axivity (Ratio: 0.93 (95% CI: 0.90, 1)); 2) time spent between 160 and 200 mg by the Axivity and the 
GENEActiv (Ratio: 0.96, (95% CI: 0.90, 1.03)), Figures 1e-f, Tables 2-5. 
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Discussion 
 
 
The Axivity, GENEActiv and ActiGraph wrist-worn raw acceleration accelerometers are widely used to assess 
physical activity in large-scale surveys (16); consequently the generation of equivalent physical activity 
outcomes from these tools would aid epidemiological comparisons. We used an open-source software package 
(GGIR) to identically process and analyse data from the three accelerometer brands to establish the degree of 
equivalence and agreement across specific activities, types of activities and the entire semi-structured pseudo 
free-living period. To the best of our knowledge, this is the first time physical activity outcomes from the 
Axivity accelerometer have been compared to those from the GENEActiv or the ActiGraph. 
 
The GENEActiv and Axivity accelerometers had excellent equivalence and agreement across the majority of 
outcome measures including acceleration (mg). However, acceleration was around 11% lower in the 
ActiGraph data. Despite this, time spent in sedentary and light intensity could be considered equivalent 
between all three accelerometers, irrespective of cut-point employed. The GENEActiv and Axivity could also 
be considered equivalent for MVPA; agreement with the ActiGraph was also high for MVPA, although not 
within the proposed 10% equivalence zone. The higher agreement between accelerometer brands evident 
when considering variables derived from acceleration, i.e. time accumulated in cut-point categories or 
acceleration ranges, rather than the acceleration itself, is consistent with our previous research comparing the 
GENEActiv and ActiGraph GT3X+ (20). The high correspondence between accelerometer brands for 
intensity categories is important as quantities of time accumulated within sedentary, light and moderate-to-
vigorous intensity cut-points are arguably the most commonly cited physical activity outcome measures.  
 
The observation protocol we employed enabled us to comprehensively evaluate the accuracy of three 
sedentary cut-points (14, 15). Sedentary/light cut-points of 40-50 mg were the most accurate at classifying 
sedentary and upright time and had higher agreement between accelerometers than 30 mg.  However, all cut-
points, irrespective of accelerometer brand were poor at classifying upright time. The inability to differentiate 
between postures using magnitude of acceleration alone has been previously reported (14, 15) with use of 
further features from the acceleration signal recommended for classification of posture (e.g. 33, 34). When 
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using cut-points or the distribution of time across acceleration ranges, it is perhaps best to think of 
classifying a spectrum of inactive to active time rather than referring to sedentary time, which infers posture 
(35). 
 
The equivalency results suggest that equivalence is worse at low accelerations (seated activities), for time 
spent at accelerations greater than 120 mg, and for time spent in MVPA, most notably for the ActiGraph. 
However, as the proposed equivalence zone is ±10% of the output magnitude, this is most likely a function of 
the low numbers involved, i.e. accelerations <20 mg and ≈4% of time spent at accelerations >120 mg. For 
example, when comparing accelerations during seated activities, the distribution of time across 40 mg 
increments in acceleration and time spent in MVPA between accelerometer brands, despite sometimes not 
reaching equivalence, fairly high ICC’s, low mean bias and relatively narrow limits of agreement were 
evident.  
 
It is possible that the closer agreement between the GENEActiv and Axivity than for either accelerometer 
with the ActiGraph is due to the taping together of the GENEActiv and Axivity accelerometers while the 
ActiGraph was worn proximal to the GENEActiv and Axivity. While this may have contributed, the 11% 
higher acceleration from the GENEActiv relative to the ActiGraph (across the total period) in the current study 
is not dissimilar to the 13-16% higher acceleration observed in our earlier studies where the GENEActiv and 
ActiGraph GT3X+ were taped together at the wrist (28) and hip (12). These consistent differences we, and 
others, have observed may relate to technical differences between the brands (12, 20, 36); specifically it 
appears there is some onboard processing of the raw acceleration signal of the ActiGraph device, but details 
of this are proprietary (36, 37). 
 
The most recent version of the ActiGraph, the GT9X Link, was used in this study. How this compares to the 
previous version, the GT3X+, which is the accelerometer that has been deployed in large surveys, e.g. 
NHANES, is important. The accelerometer sensor in the GT9X is the same as the sensor in GT3X+ so good 
comparability between the two would be anticipated; perhaps more importantly there are differences in the 
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design of the devices that may affect orientation when worn.  However, this should affect individual axis 
output rather than resultant metrics, such as the ENMO average acceleration metric. Recently, Montoye and 
colleagues (38) presented a comparison of the GT9X and GT3X+ ActiGraphs. They reported that raw 
acceleration data were highly correlated between models. Further, our results comparing the GT9X to the 
GENEActiv are very similar to those from our previous comparison of the GT3X+ to the GENEActiv (20). 
 
Strengths of this study include the large range of sedentary and light activities incorporated in a simulated 
free-living protocol designed to encourage a range of natural self-paced behaviours common in normal daily 
life. This elicited an average acceleration across the total period similar to the daily average acceleration 
observed in free-living individuals (6), strengthening the ecological validity of the results. The observation 
facilitated the evaluation of specific activities and the accuracy and comparability of sedentary/light 
thresholds. The evaluation of the agreement of key physical activity outcomes between accelerometer brands 
will facilitate selection of the most appropriate outcomes to use when comparing studies which have used 
different accelerometer brands. Critically, the GGIR accelerometer processing package used in this study (17, 
18, 19) can be easily applied to large datasets and is available open-source, as is the function we created to 
convert Axivity raw files to a format that can be analysed in GGIR. Limitations of the study include: the small 
sample size, although the study was powered appropriately; the self-selected homogenous young fit cohort; 
and the relatively small amount of time spent in MVPA, given the focus of our protocol design on sedentary 
and light activities. Further, the short duration of the study precluded the examination of sleep and the range 
of behaviours across a 24 h day.  
 
In conclusion, this study suggests that key physical activity outcomes from GGIR (acceleration and time spent 
in intensity cut-points) can be considered equivalent between the Axivity and GENEActiv accelerometers. 
Comparability with the ActiGraph is reduced, with acceleration and MVPA approximately 9-11% lower; 
however time spent sedentary and time in light intensity activity can be considered equivalent. It should be 
noted that these results are generalisable only to studies using the same wear location (non-dominant wrist) 
and processing the data in GGIR. To ensure the comparability of the accelerometer brands was tested, and not 
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confounded by differences in wear location, all accelerometer brands were worn on the non-dominant wrist. 
This is common practise in most studies (e.g. 6, 9, 21, 22, 23, 24), but a notable exception is UK Biobank 
where the Axivity was worn on the dominant wrist (4). The next step is to examine the agreement between 
accelerometer brands as they are commonly used, i.e. in a true free-living environment with the GENEActiv 
and ActiGraph again on the non-dominant wrist, but the Axivity on the dominant wrist, as in UK Biobank.  
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Table 1. Physical activity outcomes (mean, SD) by monitor (GENEActiv, Axivity, ActiGraph) 
 
 
 
Note: all activities approx 2 h, seated only 1 h 20, upright only 24 min. Note total time includes all observed activities 
and transitions 
All and upright activities: GENEActiv N = 19, Axivity N = 17, ActiGraph N = 18 
Seated activities: GENEActiv N = 18, Axivity N = 16, ActiGraph N = 18 
 21   
Mean Standard deviation   
GENEActiv Axivity ActiGraph GENEActiv Axivity ActiGraph 
 
Acceleration (mg) 
Total period 42.1 40.9 37.8 10.3 11.5 11.2 
Seated only 13.1 13.8 12.7 4.3 6.5 5.1 
Upright only 87.3 83.8 78.9 25.5 24.7 24 
 
Individual activities 
      
Seated Reading 10.6 11.5 9.8 4.7 7.4 5.6  
Eating 20.2 21.6 20.1 7.5 8.7 9.8  
Computer 11.4 12.1 12.3 4.6 7.1 7.4  
TV 11.1 10.7 9.5 6.5 8.6 6.5 
 
Upright Standing still 16.6 13.2 18.7 20.6 10.6 21.4  
Walking 160 151.4 139.8 52.7 61.7 44.3  
Sweeping 187.7 176.7 175.5 92.7 84.3 81  
Washing pots 60.2 61.4 53.9 18.6 20.4 19.5  
Dusting 78.6 75 70.9 40.6 37.8 37.4  
Standing 
computer 
20.7 21.6 14.4 8.5 7.8 8.4 
 
% Time in cut-point categories 
Total time Cut-point (mg) 
      
Sedentary <30 67.6 67.5 69.7 7.4 7.7 6.4  
<40 72.2 72.4 74.5 6.6 6.4 5.7  
<50 75.7 76.2 77.8 5.9 5.7 5.3 
 
Light 30-100 18.8 19.5 18.4 5.3 5.8 2.9  
40-100 14.2 14.6 13.7 4.4 4.3 2.1  
50-100 10.7 10.8 10.3 3.6 3.4 1.6 
 
MVPA >100 13.6 13.0 11.9 3.5 4.0 4.4 
 
% Accuracy of sedentary cut-points for % time seated only and upright  
Cut-point (mg) 
      
Seated only <30 89.2 87.6 89.2 6.2 7.2 7.0 
<40 91.8 91.0 92.3 5.6 6.0 6.1 
<50 93.6 93.1 94.1 5.1 5.5 5.4 
 
Upright >30 37.8 39.1 40.3 4.9 5.3 6.2  
>40 44.6 45.7 46.7 5.2 5.8 6.6  
>50 49.8 51.0 51.7 5.6 6.8 7.2 
 
% time in 40 mg incremental ranges 
Total time Range (mg) 
      
 
0-40 72.2 72.4 74.5 6.6 6.4 5.7  
40-80 10.8 11.2 10.3 3.3 3.3 1.8  
80-120 6.4 6.2 6.0 2.3 1.9 1.0  
120-160 4.2 4.2 3.8 1.2 1.2 1.2  
160-200 2.5 2.5 2.3 0.9 1.1 1.2  
>200 4.0 3.5 3.1 2.7 2.4 2.5 
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Table 2. Agreement between pairs of monitors (GENEActiv/ActiGraph, GENEActiv/Axivity, Axivity/ActiGraph) for average dynamic acceleration.    
Intra-class correlation (ICC)a Agreement (Bland and Altman)b Equivalencyc   
ICC  
(95% CI) 
mean bias 95% limits of 
agreement 
Can be considered 
equivalent (see Figure 
1)  
Monitor 1 GEN GEN Ax GEN GEN Ax GEN GEN Ax GEN GEN Ax  
Monitor 2 ActiG Ax ActiG ActiG Ax ActiG ActiG Ax ActiG ActiG Ax ActiG 
Total period 
 
0.86  
(0.56, 0.95) 
0.95  
(0.87, 0.98) 
0.82  
(0.50, 0.94) 
3.3 -0.1 3.6 9.6 6.8 12.0 ×  × 
Seated only 
 
0.73  
(0.40, 0.89) 
0.85  
(0.62, 0.95) 
0.59  
(0.15, 0.84) 
0.6 -0.6 1.3 7.0 6.1 10.2 × × × 
Upright  
 
0.87  
(0.40, 0.96) 
0.97  
(0.91, 0.99) 
0.75  
(0.28, 0.92) 
9.0 -0.9 10.2 19.6 11.6 26.6 ×  × 
              
Seated 
activities 
Reading 0.67  
(0.31, 0.87) 
0.79  
(0.48, 0.92) 
0.37 
(-0.15, 0.73) 
1.1 -0.8 1.7 4.3 4.1 7.4 × × × 
 
Eating 0.82  
(0.56, 0.93) 
0.89  
(0.70, 0.96) 
0.64  
(0.22, 0.86) 
5.3 3.8 8.1 5.3 3.8 8.1 × × × 
 
Computer 0.60  
(0.17, 0.84) 
0.83 
(0.58, 0.94) 
0.49  
(-0.04, 0.80) 
-0.1 -0.4 0.5 5.6 3.7 7.6 × × × 
 
TV 0.79  
(0.51, 0.92) 
0.90  
(0.73, 0.97) 
0.79  
(0.50, 0.92) 
1.4 0.2 1.6 4.1 3.7 4.9 × × × 
              
Upright 
activities 
Standing still 0.95  
(0.88, 0.98) 
0.90  
(0.75, 0.96) 
0.68  
(0.27, 0.88) 
-0.9 -1.0 -1.1 13.2 9.1 19.1 × × × 
 
Walking 0.87  
(0.56, 0.96) 
0.98  
(0.95, 0.99) 
0.83  
(0.52, 0.94) 
13.9 -3.6 16.0 39.5 19.3 54.8 ×  × 
 Sweeping 0.95  
(0.58, 0.99) 
0.99  
(0.97, 0.99) 
0.94  
(0.74, 0.98) 
20.1 4.6 16.9 36.2 24.4 46.2 ×  × 
 
Washing 
pots 
0.85  
(0.52, 0.94) 
0.92 
(0.79, 0.97) 
0.80  
(0.45, 0.93) 
6.2 -0.5 6.5 20.5 14.7 21.9 ×  × 
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Intra-class correlation (ICC)a Agreement (Bland and Altman)b Equivalencyc   
ICC  
(95% CI) 
mean bias 95% limits of 
agreement 
Can be considered 
equivalent (see Figure 
1)  
Monitor 1 GEN GEN Ax GEN GEN Ax GEN GEN Ax GEN GEN Ax  
Monitor 2 ActiG Ax ActiG ActiG Ax ActiG ActiG Ax ActiG ActiG Ax ActiG  
Dusting 0.94  
(0.68, 0.98) 
0.99  
(0.98, 0.99) 
0.91  
(0.57, 0.98) 
9.4 0.2 10.1 22.0 9.4 23.3 ×  × 
 
Standing 
computer 
0.70  
(0.02, 0.91) 
0.60  
(0.18, 0.84) 
0.37  
(-0.11,0.74) 
5.4 -2.1 8.0 9.4 13.4 14.0 × × × 
              
 
ActiG = ActiGraph GT9X; Ax = Axivity; GEN = GENEActiv,  
aSingle measure, absolute agreement. All p < 0.05 apart from Axivity/ActiGraph ENMO for the specific activities reading (seated), computer (seated) and 
standing computer (upright) 
bBland and Altman: Bias calculated as Monitor 1 - Monitor 2 
c95% confidence interval (CI) for mean of second monitor falls into the proposed equivalence zone (i.e. +/-10% of the mean) of the mean of the first 
monitor. 
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Table 3. Agreement between pairs of monitors (GENEActiv/ActiGraph, GENEActiv/Axivity, Axivity/ActiGraph) for % time in cut-point categories.  
   
Intra-class correlation (ICC)a Agreement (Bland and Altman)b Equivalencyc   
ICC  
(95% CI) 
mean bias 95% limits of 
agreement 
Can be considered 
equivalent (see 
Figure 1)  
Monitor 1 GEN GEN Ax GEN GEN Ax GEN GEN Ax GEN GEN Ax  
Monitor 2 ActiG Ax ActiG ActiG Ax ActiG ActiG Ax ActiG ActiG Ax ActiG 
Sedentary <30 0.84  
(0.63, 0.94) 
0.95  
(0.87, 0.98) 
0.87  
(0.64, 0.96) 
-0.9 0.3 -1.5 6.3 4.9 6.1    
 
<40 0.89  
(0.69, 0.96) 
0.96  
(0.88, 0.99) 
0.90  
(0.61, 0.97) 
-1.2 0.0 -1.5 4.3 4.0 4.0    
 
<50 0.90  
(0.70, 0.97) 
0.96  
(0.89, 0.99) 
0.92  
(0.68, 0.98) 
-1.1 -0.2 -1.3 3.6 3.4 3.4    
              
Light 30-100 0.70  
(0.36, 0.88) 
0.95  
(0.86, 0.98) 
0.69  
(0.29, 0.88) 
-0.5 -0.4 0.0 4.2 3.8 5.5    
 
40-100 0.86  
(0.66, 0.95) 
0.96  
(0.90, 0.99) 
0.79  
(0.47, 0.92) 
-0.2 -0.2 0.1 2.1 2.5 3.1    
 
50-100 0.89  
(0.73, 0.96) 
0.97  
(0.92, 0.99) 
0.83  
(0.56, 0.94) 
-0.3 0.0 -0.2 1.4 1.8 2.1    
              
MVPA >100 0.85  
(0.47, 0.95) 
0.96  
(0.88, 0.98) 
0.84  
(0.49, 0.95) 
1.4 0.1 1.5 3.4 2.3 4.1 ×  × 
 
ActiG = ActiGraph GT9X; Ax = Axivity; GEN = GENEActiv,  
aSingle measure, absolute agreement. All p < 0.05 apart from Axivity/ActiGraph ENMO for the specific activities reading (seated), computer (seated) and 
standing computer (upright) 
bBland and Altman: Bias calculated as Monitor 1 - Monitor 2 
c95% confidence interval (CI) for mean of second monitor falls into the proposed equivalence zone (i.e. +/-10% of the mean) of the mean of the first 
monitor. 
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Table 4. Agreement between pairs of monitors (GENEActiv/ActiGraph, GENEActiv/Axivity, Axivity/ActiGraph) for % accuracy of sedentary cut-points.  
 
   
Intra-class correlation (ICC)a Agreement (Bland and Altman)b Equivalencyc   
ICC  
(95% CI) 
mean bias 95% limits of 
agreement 
Can be considered 
equivalent (see 
Figure 1)  
Monitor 1 GEN GEN Ax GEN GEN Ax GEN GEN Ax GEN GEN Ax  
Monitor 2 ActiG Ax ActiG ActiG Ax ActiG ActiG Ax ActiG ActiG Ax ActiG 
Seated 
activities 
only 
<30 0.88  
(0.70, 0.96) 
0.92  
(0.77, 0.97) 
0.80  
(0.50, 0.93) 
-0.4 1.3 -1.6 6.6 4.9 8.9    
<40 0.95  
(0.86, 0.98) 
0.96  
(0.89, 0.99) 
0.90 
(0.70, 0.97) 
-0.8 0.7 -1.4 3.6 3.0 4.9    
<50 0.97  
(0.89, 0.99) 
0.99  
(0.96, 0.99) 
0.95  
(0.78, 0.98) 
-0.7 0.4 -1.1 2.3 1.7 3.0    
  
         
   
Upright 
activities 
only 
>30 0.65  
(0.25, 0.86) 
0.83  
(0.58, 0.94) 
0.76  
(0.19, 0.93) 
-2.4 -0.3 -2.7 8.3 5.5 6.0 ×  × 
>40 0.78  
(0.45, 0.92) 
0.90  
(0.73, 0.96) 
0.79  
(0.29, 0.94) 
-1.9 0.0 -2.6 6.6 4.7 6.1    
>50 0.82  
(0.55, 0.93) 
0.92  
(0.78, 0.97) 
0.83  
(0.49, 0.94) 
-1.7 0.0 -2.2 6.6 4.8 6.8    
 
ActiG = ActiGraph GT9X; Ax = Axivity; GEN = GENEActiv,  
aSingle measure, absolute agreement. All p < 0.05 apart from Axivity/ActiGraph ENMO for the specific activities reading (seated), computer (seated) and 
standing computer (upright) 
bBland and Altman: Bias calculated as Monitor 1 - Monitor 2 
c95% confidence interval (CI) for mean of second monitor falls into the proposed equivalence zone (i.e. +/-10% of the mean) of the mean of the first 
monitor. 
x  Could be considered equivalent when the alternate accelerometer (monitor 2) was selected as the reference.  
Note: All and upright activities: GENEActiv N = 19, Axivity N = 17, ActiGraph N = 18; Seated activities: GENEActiv N = 18, Axivity N = 16, ActiGraph N = 18 
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Table 5. Agreement between pairs of monitors (GENEActiv/ActiGraph, GENEActiv/ActiGraph, Axivity/ActiGraph) for distribution of time across 40 mg 
increments of acceleration 
 
   
Intra-class correlation (ICC)a Agreement (Bland and Altman)b Equivalencyc   
ICC  
(95% CI) 
mean bias 95% limits of 
agreement 
Can be considered 
equivalent (see 
Figure 1)  
Monitor 1 GEN GEN Ax GEN GEN Ax GEN GEN Ax GEN GEN Ax  
Monitor 2 ActiG Ax ActiG ActiG Ax ActiG ActiG Ax ActiG ActiG Ax ActiG  
0-40 0.89  
(0.69, 0.96) 
0.96  
(0.88, 0.99) 
0.90  
(0.61, 0.97) 
-1.17 0.03 -1.54 4.3 4.0 4.0    
 
40-80 0.82  
(0.57, 0.93) 
0.95  
(0.86, 0.98) 
0.78  
(0.47, 0.92) 
-0.10 -0.25 0.33 2.1 2.2 2.7    
 
80-120 0.90  
(0.74, 0.96) 
0.94  
(0.83, 0.98) 
0.78  
(0.47, 0.92) 
-0.02 0.23 -0.19 0.8 1.5 1.3    
 
120-160 0.77  
(0.48, 0.91) 
0.94  
(0.83, 0.98) 
0.80  
(0.50, 0.93) 
0.29 0.06 0.29 1.4 0.8 1.4 ×  × 
 
160-200 0.79  
(0.52, 0.92) 
0.93  
(0.82, 0.98) 
0.71  
(0.35, 0.89) 
0.17 -0.10 0.33 1.4 0.8 1.8 × × × 
 
>200 0.89  
(0.51, 0.97) 
0.97  
(0.93, 0.99) 
0.81  
(0.46, 0.93) 
0.84 0.02 0.78 1.9 1.1 2.6 ×  × 
 
ActiG = ActiGraph GT9X; Ax = Axivity; GEN = GENEActiv,  
aSingle measure, absolute agreement. All p < 0.05 apart from Axivity/ActiGraph ENMO for the specific activities reading (seated), computer (seated) and 
standing computer (upright) 
bBland and Altman: Bias calculated as Monitor 1 - Monitor 2 
c95% confidence interval (CI) for mean of second monitor falls into the proposed equivalence zone (i.e. +/-10% of the mean) of the mean of the first 
monitor. 
x  Could be considered equivalent when the alternate accelerometer (monitor 2) was selected as the reference.  
Note: All and upright activities: GENEActiv N = 19, Axivity N = 17, ActiGraph N = 18; Seated activities: GENEActiv N = 18, Axivity N = 16, ActiGraph N = 1  
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Figure 1 Equivalence between pairs of accelerometer brands for a) acceleration, b) acceleration during individual seated activities, c) acceleration 
during individual upright activities, d) % time spent within cut-point categories, e) sedentary cut-point accuracy, and f) % time spent in incremental 
40 mg ranges. 
 
 
 
 
GENEActiv/ActiGraph 
GENEActiv/Axivity 
Axivity/ActiGraph 
Error bars represent the 95% confidence interval of the ratio. Equivalence = 1 (solid line), proposed 
equivalence zone (i.e. +/-10% of the mean) represented by dashed vertical lines. 
 
Black marker denotes the 95% confidence interval (CI) for the mean of the second monitor falls into 
the proposed equivalence zone of the mean of the first monitor, blue marker denotes it falls outside 
the proposed equivalence zone. 
*Could be considered equivalent when the alternate accelerometer was selected as the reference (see 
text for details) 
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